Page 7 - Analytical Testing News Today

CELLINK launches all-in-one imager, single-cell dispenser The UP.SIGHT single-sell dispensing system is designed to boost efficiency in cell-line development workflows and offer double assurance of clonality. CELLINK’s cytena GmbH division has launched the UP.SIGHT system, equipped with single-cell dispensing technology and rapid imaging system. The product is intended permit nozzle imaging and 3D full well imaging, and offer double assurance of clonality courtesy ...

Share this article Share this article ResearchAndMarkets.coms offering. The global cannabis testing market is expected to reach USD 1,806 million by 2025 from USD 962 million in 2020, at a CAGR of 13.4% during the forecast period. The growth in this market is mainly driven by factors such as the legalization of medical cannabis and the growing number of cannabis testing laboratories (specifically in the US), the growing adoption of LIMS in cannabis testing laboratories, and increasing awarene...

Calyx spins off medical imaging, eClinical solutions firm Formerly Parexel Informatics, the renamed clinical research technology company has broken off and will operate as an independent company going forward. Calyx—a UK-based company offering medical imaging, eClinical and regulatory services to clinical research clients—has shed the name Parexel Informatics in favor of its new moniker. After this strategic separation, the company will continue its work pursuing...

(2) LANGLEY, BC / ACCESSWIRE / December 23, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the signing of a term sheet for the acquisition of Phyto Extractions Brands ("Phyto Extractions") and permitting of its hydrocarbon extraction expansion. Further to its news release on October 7, 2020, Adastra has signed a term sheet with a BC-based company for the acquisi...

Adastra Signs Joint Venture Agreement with JOYN Botanicals to Solidify Cannabis 3.0 Edible and Beverage Technology Partnership LANGLEY, BC / ACCESSWIRE / December 18, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce it has signed a joint venture ("JV") agreement with JOYN Botanicals Ltd. ("JOYN") for the exploitation of JOYNs patent-pending soluble cannabis powder...

JOYN Botanicals Ltd.: JOYN Botanicals Signs Joint Venture Agreement with Cannabis Processor Adastra Labs, to Manufacture and Bring Solucann Powder to Cannabis 3.0 Market Gluten free Under the terms of the Joint Venture Agreement, Adastra and JOYN will create a combined entity to leverage the Solucann technology across the Canadian marketplace. Key objectives of the partnership include developing and bringing to market Solucann products that have broad applicability to the CPG segment. "We at JO...

(2) LANGLEY, BC / ACCESSWIRE / December 18, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce it has signed a joint venture ("JV") agreement with JOYN Botanicals Ltd. ("JOYN") for the exploitation of JOYNs patent-pending soluble cannabis powder. Joint Venture Terms Under the terms of the JV agreements, Adastra and JOYN have incorporated Solucann Holdings Ltd. ("Sol...

Adastra Labs Holdings Ltd.: Adastra Near-Doubles Quarter on Quarter Revenue and Reports Financial Results for the Q3 2020 Quarter-over-quarter gross revenue increased 190% to $825 thousand in Q3 2020 Gross revenue was improved by the continuing relationship with CannMart Inc., combined with our biomass agreement with Pure Sunfarms which allows for a steady supply of quality input material. Adastra ended the quarter with a total cash balance of $2.3 million A non-brokered private placement for g...